Page 2 - Rick Bartram News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Esperion strikes deals that add $80 million to cash pile Esperion strikes deals that add $80 million to cash pile Esperion markets one of its approved cholesterol drugs as Nexletol in the U.S. Two new cash-generating deals were announced Monday by drugmaker Esperion Therapeutics Inc. as it works to commercialize its cholesterol-lowering drugs around the world. The Ann Arbor-based cholesterol-focused biotechnology company said it had reached a deal with Japanese pharma firm Daiichi Sankyo Company Ltd. to distribute its drugs in several countries in Asia with possible expansion to countries in ...

Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Esperion Therapeutics Inc (NASDAQ: ESPR) Popular Searches Operator Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today's conference call may be recorded. I would now like to hand the conference call over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir. This article is a transcript of this conference call produced for...